Russian Covid-19 vaccine tested on people, good effect reported
2 Jul '20
A Russian Covid-19 vaccine has been unofficially tested on humans. Scientists at the Gamaleya National Research Center of Epidemiology and Microbiology (NRCEM) in Moscow tested their new vector vaccine on themselves, and the experiment is said to have been successful as immunity showed enough strength, the Russian news daily Interfax reported, citing NRCEM CEO Academician Alexander Ginzburg.
When asked if any adverse side effects were detected, the scientist said, “No, all are safe and sound, and happy.” He stopped short of specifying how many colleagues had injected the vaccine in themselves, but said that this was a “wide circle of employees, including the actual developers, preclinical trials managers, and technologists.”
Mr. Ginzburg explained that their solution was a vaccine based on adenovirus DNA, into which the SARS-CoV-2 coronavirus gene had been built. The adenovirus was used as a “container” to deliver the gene to cells, start protein synthesis there to grow the shell of a new coronavirus (the very “”corona,” or crown, the virus owes its name to), and “introduce” the immune system to the potential adversary. Vaccines of such type are typically referred to as vector ones.